Clinical Trials
3 trialsNCT00912912 2016-04-15
Sunitinib Malate in Refractory Germ Cell Tumors
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01215578 2015-04-30
NET
Assistance Publique - Hôpitaux de Paris
Phase 2 Terminated
NCT00371553 2009-07-08
Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer
British Columbia Cancer Agency
Phase 2 Completed